prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - antígenos de superficie del virus de la gripe (hemaglutinina y neuraminidasa) de la cepa a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacunas - inmunización activa contra el subtipo h5n1 del virus influenza a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptina, metformin hidrocloruro - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).
cosentyx (secukinumab) 150 mg/ml solucion inyectable en jeringa prellenada
novartis de venezuela s.a. - secukinumab -
cosentyx (secukinumab) 150mg polvo liofilizado para solucion inyectabl
novartis de venezuela, s.a. - secukinumab -
signifor lar 20 mg polvo para suspension inyectable
novartis de venezuela, s.a. - pasireotida - polvo para suspension inyectable - 20 mg
signifor lar 40 mg polvo para suspension inyectable
novartis de venezuela, s.a. - pasireotida - polvo para suspension inyectable - 40 mg
signifor lar 60 mg polvo para suspension inyectable
novartis de venezuela, s.a. - pasireotida - polvo para suspension inyectable - 60 mg
miflonide breezhaler 200 microgramos polvo para inhalacion (capsula dura)
novartis farmaceutica s.a. - budesonida - polvo para inhalaciÓn - 200 microgramos/dosis - budesonida 200 microgramos - budesonida
miflonide breezhaler 400 microgramos polvo para inhalacion (capsula dura)
novartis farmaceutica s.a. - budesonida - polvo para inhalaciÓn - 400 microgramos/dosis - budesonida 400 microgramos - budesonida
enviage
novartis europharm ltd. - aliskiren - hipertensión - agentes que actúan sobre el sistema renina-angiotensina - el tratamiento de la hipertensión esencial.